SPO vs SPI: which cracking growth prospect should you buy?

Can Sportech plc (LON:SPO) or Spirent Healthcare plc (LON:SPI) add growth to your portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two stocks with tasty growth prospects, Sportech (LSE: SPO) and Spire Healthcare (LSE: SPI), both reported today, but which one should you go for? Let’s take a look at them.

Sporting boost

Sportech shares are up 6% as I write, as the markets are ingesting a whole load of news from the sports betting operator and technology supplier. Headlines from 2016 full-year results include an adjusted pre-tax profit rise of 17% to £13.8m, with adjusted earnings per share up 18% to 5.2p.

But the big item is the change in the company’s cash position. Despite a non-cash impairment of £63.7m due to a review of assets, the overall balance sheet strengthened by £22.6m — and Sportech turned a £57.7m adjusted net debt at the end of 2015 into adjusted net cash of £36.5m.

Some of that cash is set to find its way back to shareholders in the form of a tender offer through which the company will invest approximately £20m in buying back around 10% of its ordinary shares.

Sportech also said its eight-year £97m VAT refund appeal has been successful, and tells us it it has agreed to sell its Football Pools subsidiary for £83m.

With the shares having almost doubled to 103p over the past 12 months, is it still time to buy?

With chief executive Ian Penrose calling it a transformational year and saying the firm is “in a strong position and more focused to take advantage of the strategic positioning of its predominantly US based businesses“, I think we could be in for good times. And analysts agree, suggesting EPS growth by 2018 that would put the shares on a lowly PEG of 0.4.

Hospital expansion

Full-year results gave shares in Spire Healthcare a 5% boost in early trading, but they’ve dropped back to 333p as I write, just 1% ahead. The price has been erratic with no overall change for around two years, so where are the growth prospects?

With 2016 revenue up 5.4% to £926.4m, adjusted profit after tax grew by 4.9% to £76.6m and adjusted EPS picked up the same percentage to 19.2p. The dividend was lifted by 2.7% to 3.8p, modestly beating inflation. The only minor downside is a 3.1% rise in net debt to £432.3m.

Cash flow conversion was strong, and the firm is expanding its operations, literally — five new operating theatres were opened in the year. A number of the firm’s hospitals saw new developments too.

Executive chairman Garry Watts said that “integration issues” at Spire St Anthony’s Hospital had impacted performance and that “the first half of 2017 will still be a period of recovery at St Anthony’s“. And with further start-up costs still to be faced at the company’s newest two hospitals, EBITDA for 2017 should be pretty much flat.

But Mr Watts reckons EPS growth will return in 2018, with demographics and pressure on the NHS helping boost Spire’s long-term prospects.

Analysts appear to think so too, and have pencilled-in a 14% rise in EPS for 2018, with the forecast dividend rising to yield 1.2%. That dividend is low, but it’s well covered, and I can see a greater proportion of Spire’s earnings being paid out in future years as the company matures further into a growing market.

The forecast suggests a P/E of around 16.5 for 2018, and I think that’s a good price — for a long-term growth prospect rather than a get-rich-quick punt.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Can investors consider buying £1 for 60p with this FTSE 250 investment trust?

Harbourvest Global Private Equity's a FTSE 250 private equity firm trading at 60% of its NAV. And investors are pushing…

Read more »

Young Woman Drives Car With Dog in Back Seat
Investing Articles

2 UK shares investors should consider keeping on a tight leash

These UK shares seem to have robust long-term tailwinds, but they’re also tackling headwinds that could result in less-than-impressive investment…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

This FTSE 100 stock’s down 21% since I bought! Have I made a BIG mistake?

FTSE 100 stocks are supposed to be less volatile. But our writer recently purchased one that’s making him question this…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Will the stock market rise in 2025, and how high could it go?

The stock market's up by double digits, but can it maintain its momentum in 2025? And which stocks should investors…

Read more »

Investing For Beginners

If an investor puts £750 a month in a Stocks and Shares ISA, here’s what they could have in 10 years

Edward Sheldon looks at how Stocks and Shares ISAs can help build wealth and also highlights some investment strategies to…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

1 US penny stock I’m avoiding like the plague

This medical penny stock's trying to capture a $100bn market opportunity after recently receiving FDA approval. But personally, I’m not…

Read more »

Investing Articles

£5,000 in savings? Here’s how to try and turn that into a £500 passive income

Zaven Boyrazian outlines how a £5,000 lump sum investment could potentially transformed into a £500 passive income stream within as…

Read more »

Elderly man giving a Christmas present to his wife
Investing Articles

Forget saving! Here’s a FTSE 100 share I’m planning to buy before Christmas

This FTSE 100 share looks like a brilliant bargain at current prices, says Royston Wild. Here's why it's on his…

Read more »